Some Ebola guidelines questioned

Experts questions questioning calls for suspending certain routine lab tests


Experts are questioning aspects of some of the Ebola guidelines that go beyond current Centers for Disease Control and Prevention (CDC) recommendations, especially those that call for suspending certain routine lab tests, according to an article on Infection Control Today.

A commentary in the journal Transfusion suggests that most individuals with suspected Ebola will have a fever due to another cause, and forgoing such testing may compromise patients' health more than any reduction in the risks to laboratory personnel.

The article says that all laboratory directors must work with infection control and safety experts to evaluate their hospital policies on potentially infectious patients to provide a safe environment.

Read the article.

 

 



December 12, 2014


Topic Area: Safety


Recent Posts

Barriers to Infection: Rethinking Mattress Cleaning

Laundering removable bed barriers provides a more effective, consistent and safer method for eliminating harmful bacteria compared to manual cleaning.


Over 1 Million Individuals Affected in Community Health Center Data Breach

No evidence of data misuse has been found so far.


Prospect Medical Holdings to Sell Crozer Health to Non-Profit Consortium

The sale includes Crozer Health’s operating assets, including all hospitals, ambulatory surgery centers, clinics and physician offices.


The Top States for Pest Infestations

Healthcare facilities are among the most popular locations for pest infestations.


Ground Broken on Wichita Biomedical Campus Project

The $172.5-million, eight-story, 350,000-square-foot building will be completed in 2026.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.